These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 8151790)

  • 1. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
    Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
    J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.
    Ou SH; Garcia-Martínez LF; Paulssen EJ; Gaynor RB
    J Virol; 1994 Nov; 68(11):7188-99. PubMed ID: 7933101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
    Berkhout B; Jeang KT
    J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.
    Ross EK; Buckler-White AJ; Rabson AB; Englund G; Martin MA
    J Virol; 1991 Aug; 65(8):4350-8. PubMed ID: 2072454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Majello B; De Luca P; Hagen G; Suske G; Lania L
    Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
    Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
    Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
    J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
    Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
    J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.